Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients? Marie Méan, MD, Andreas Limacher, PhD,

Slides:

Advertisements

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Advertisements

Pierre Charbel Atallah, MD, Pierre Atallah, MD, Vikram Kashyap, MD

Severe Tuberculosis Sepsis in an Immunocompetent Patient

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

Pneumothorax Recurrence Related to High-speed Lift

Bleeding Toes in Diabetic Neuropathy

Pierre Loulergue, MD, MSc, Agnès Guerre, MD

The Effect of Smoking on the Risk of Sciatica: A Meta-analysis

Russell D. Hull, MBBS, MSc, Graham F. Pineo, MD, Rollin F

An Unusual Cause of Leg Ulcerations

Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review Shelley R. Salpeter, MD, Jacob S.

Richard V. Milani, MD, Carl J. Lavie, MD, Robert M

Bleeding Toes in Diabetic Neuropathy

Alexander A. Leung, MD, MPH, Finlay A. McAlister, MD, MSc, Samuel R. G

Paul D. Stein, MD, Russell D. Hull, MBBS, MSc, Fadi Matta, MD, Abdo Y

Predicting recurrence after unprovoked venous thromboembolism: prospective validation of the updated Vienna Prediction Model by Tobias Tritschler, Marie.

Pierre Loulergue, MD, MSc, Agnès Guerre, MD

Samy Suissa, PhD, Abbas Kezouh, PhD, Pierre Ernst, MD, MSc

Sudden Cardiac Death, Mitral Valve Prolapse, and Long QT Syndrome

Leslie R. Harrold, MD, MPH, Daniel Peterson, MS, Ashley J

Shakaib U. Rehman, MD, Paul J. Nietert, PhD, Dennis W

Venous Thromboembolism with Chronic Liver Disease

Overview of Current Learning Theories for Medical Educators

Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study Nicolas Faller, MD, PhD,

Epidemiology of Myelodysplastic Syndromes

Is There Cross-Reactivity Between Penicillins and Cephalosporins?

Marc Carrier, MD, MSc, Alok A

The Effect of a Statewide Smoking Ordinance on Acute Myocardial Infarction Rates Paul Basel, BS, Becki Bucher Bartelson, PhD, Marie Claire Le Lait, MS,

Russell D. Hull, MBBS, MSc, Graham F. Pineo, MD, Rollin F

Robert Goulden, MBBS, MSc, MPhil, MA The American Journal of Medicine

Family History for Venous Thromboembolism and the Risk for Recurrence

An Uncommon Cause of Recurrent Venous Thromboembolism

The Reply The American Journal of Medicine

Carmelo V. Venero, MD, Paul D. Thompson, MD, Antonio B. Fernandez, MD

Hong-Tao Tie, MD, Rui Shi, MD The American Journal of Medicine

Gun Ownership and Firearm-related Deaths

History of Thyroid Disorders in Relation to Clinical Outcomes in Atrial Fibrillation Helene Bruere, MD, Laurent Fauchier, MD, PhD, Anne Bernard Brunet,

Gout in African Americans

Adult-Onset Homocystinuria Arteriopathy Mimics Fibromuscular Dysplasia

Lifetime Risk of Venous Thromboembolism in Two Cohort Studies

Carlos Aguilar, MD, Valentin del Villar, MD

Subclinical Hypothyroidism and the Risk of Coronary Heart Disease: A Meta-Analysis Nicolas Rodondi, MD, MAS, Drahomir Aujesky, MD, MS, Eric Vittinghoff,

Repeated Hemoglobin A1C Ordering in the VA Health System

Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome?

Jonathan D. Kirsch, MD, Alisa Duran, MD, Alexander M

Disseminated Zoster After Trauma in an Immunocompetent Patient

Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study Walid Saliba, MD, MPH, Naomi.

Prevalence and Risk Factors for Erectile Dysfunction in the US

Opioid Use, Misuse, and Abuse in Patients Labeled as Fibromyalgia

Age Differences in Treatment and Control of Hypertension in US Physician Offices, : A Serial Cross-sectional Study Anna Gu, MD, PhD, Yu Yue,

To Reduce Stroke with PFO Closure, Respect the Shunt

John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J

Evaluation of Severe Infection and Survival After Splenectomy

One-way Versus Two-way Text Messaging on Improving Medication Adherence: Meta- analysis of Randomized Trials David S. Wald, MD, FRCP, Shahena Butt, MSc,

Purple Urinary Bag Syndrome

A Post-cure Complication

Sister Mary Joseph's Node

Plasma Lactescence in Acute Pancreatitis

Risk of Falls and Major Bleeds in Patients on Oral Anticoagulation Therapy Jacques Donzé, MD, MSc, Carole Clair, MSc, MD, Balthasar Hug, MD, MBA, MPH,

Primary Care Management of Skin Abscesses Guided by Ultrasound

Rebecca D. Chason, Joan S. Reisch, PhD, Don C. Rockey, MD

The Association Between Barium Examination and Subsequent Appendicitis: A Nationwide Population-Based Study Hao-Ming Li, MD, Lee-Ren Yeh, MD, Ying-Kai.

Acquired Generalized Lipodystrophy Following Immune Thrombocytopenia

Falls in Older Adults: Risk Assessment, Management and Prevention

Has mortality from acute renal failure decreased

Emily G. McDonald, MD, MSc, Ramy R. Saleh, MD, Todd C. Lee, MD, MPH

Toward a More Responsible News Media

David Tian, MD, Ram Jhingan Mohan, MD, Gary Stallings, MD

Preoperative Thienopyridine Use and Outcomes after Surgery: A Systematic Review Anita G. Au, MD, Sumit R. Majumdar, MD MPH, Finlay A. McAlister, MD MSc

Hypophosphatemia: Diagnostic Significance in Legionnaires’ Disease

Presentation transcript:

Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients? Marie Méan, MD, Andreas Limacher, PhD, Odile Stalder, MSc, Anne Angelillo-Scherrer, MD, Lorenzo Alberio, MD, Pierre Fontana, MD, PhD, Hans-Jürg Beer, MD, Nicolas Rodondi, MD, MAS, Bernhard Lämmle, MD, Drahomir Aujesky, MD, MSc The American Journal of Medicine Volume 130, Issue 10, Pages 1220.e17-1220.e22 (October 2017) DOI: 10.1016/j.amjmed.2017.05.026 Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure Cumulative incidence of recurrent venous thromboembolism. The cumulative 36-month incidence of venous thromboembolism was 12.9% (95% confidence interval [CI], 5.1%-30.8%) in patients with a Factor V Leiden, 18.5% (95% CI, 4.9%-56.5%) in patients with a prothrombin G20210A, and 16.7% (95% CI, 12.5%-22.1%) in patients without mutation (P = .91 by the log-rank test). The American Journal of Medicine 2017 130, 1220.e17-1220.e22DOI: (10.1016/j.amjmed.2017.05.026) Copyright © 2017 Elsevier Inc. Terms and Conditions